Fenfluramine in clinical practice: new therapy option for Dravet and LennoxGastaut syndromes springermedizin.de Efficacy and safety of anti obesity drugs in metabolic dysfunction associated steatotic liver disease: An updated review Low Dose Naltrexone Liv Wellness RX Research Summary: Once weekly 9 mg mazdutide led to 17% mean weight loss vs 2% with placebo among Chinese adults with #obesity, but most recipients reported mild or moderate gastrointestinal symptoms. #ADA2026 #ADASciSessions Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C19*1 *17 genotype suggesting a rapid metabolizer status The Pharmacogenomics Journal GLP 1s can support change and healthy habits are what make it last , Our Proactive Health Microdose GLP 1 Program brings together medication, biomarker insights, and digital habit tools to help